Attention all new applicants
Effective July 1, 2021, MSK will require all new hires, volunteers, and vendors who come onsite to provide proof of COVID-19 vaccination based on the vaccines' high level of protection and our shared responsibility in protecting our patients. Read more
Leading the Fight Against Cancer, One Patient at a Time
Division of Hematologic Malignancies
The Division of Hematologic Malignancies specializes in treating patients with blood cancers and some benign hematologic diseases. This includes leukemia, lymphoma, multiple myeloma and benign blood disorders.
Each year, we oversee more than 450 bone marrow and stem cell transplants, which include both autologous and allogeneic procedures.
Our team works closely scientists to develop groundbreaking therapies and offer the latest treatment options to our patients.